275 related articles for article (PubMed ID: 1786515)
1. Inhibition of the release of endothelium-derived relaxing factor in vitro and in vivo by dipeptides containing NG-nitro-L-arginine.
Thiemermann C; Mustafa M; Mester PA; Mitchell JA; Hecker M; Vane JR
Br J Pharmacol; 1991 Sep; 104(1):31-8. PubMed ID: 1786515
[TBL] [Abstract][Full Text] [Related]
2. Endothelial cells metabolize NG-monomethyl-L-arginine to L-citrulline and subsequently to L-arginine.
Hecker M; Mitchell JA; Harris HJ; Katsura M; Thiemermann C; Vane JR
Biochem Biophys Res Commun; 1990 Mar; 167(3):1037-43. PubMed ID: 2322257
[TBL] [Abstract][Full Text] [Related]
3. Potentiation of the vasorelaxant activity of nitric oxide by hydroxyguanidine: implications for the nature of endothelium-derived relaxing factor.
Zembowicz A; Swierkosz TA; Southan GJ; Hecker M; Vane JR
Br J Pharmacol; 1992 Dec; 107(4):1001-7. PubMed ID: 1281716
[TBL] [Abstract][Full Text] [Related]
4. The involvement of endothelium-derived relaxing factor in the regulation of renal cortical blood flow in the rat.
Walder CE; Thiemermann C; Vane JR
Br J Pharmacol; 1991 Apr; 102(4):967-73. PubMed ID: 1855125
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of the endothelium-dependent relaxation induced by NG-hydroxy-L-arginine.
Zembowicz A; Swierkosz TA; Southan GJ; Hecker M; Gryglewski RJ; Vane JR
J Cardiovasc Pharmacol; 1992; 20 Suppl 12():S57-9. PubMed ID: 1282987
[TBL] [Abstract][Full Text] [Related]
6. Nitric oxide and another potent vasodilator are formed from NG-hydroxy-L-arginine by cultured endothelial cells.
Zembowicz A; Hecker M; Macarthur H; Sessa WC; Vane JR
Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11172-6. PubMed ID: 1662386
[TBL] [Abstract][Full Text] [Related]
7. NG-hydroxy-L-arginine and hydroxyguanidine potentiate the biological activity of endothelium-derived relaxing factor released from the rabbit aorta.
Zembowicz A; Chłopicki S; Radziszewski W; Vane JR; Gryglewski RJ
Biochem Biophys Res Commun; 1992 Dec; 189(2):711-6. PubMed ID: 1472042
[TBL] [Abstract][Full Text] [Related]
8. L-arginine, but not N alpha-benzoyl-L-arginine ethyl ester, is a precursor of endothelium-derived relaxing factor.
Fasehun OA; Gross SS; Rubin LE; Jaffe EA; Griffith OW; Levi R
J Pharmacol Exp Ther; 1990 Dec; 255(3):1348-53. PubMed ID: 2175803
[TBL] [Abstract][Full Text] [Related]
9. L-nitroarginine increases blood pressure in the rat.
Kobayashi Y; Ikeda K; Shinozuka K; Nara Y; Yamori Y; Hattori K
Clin Exp Pharmacol Physiol; 1991 Jun; 18(6):397-9. PubMed ID: 1914242
[TBL] [Abstract][Full Text] [Related]
10. The effect of NG-nitro-L-arginine methyl ester upon basal blood flow and endothelium-dependent vasodilatation in the dog hindlimb.
White DG; Drew GM; Gurden JM; Penny DM; Roach AG; Watts IS
Br J Pharmacol; 1993 Mar; 108(3):763-8. PubMed ID: 8467362
[TBL] [Abstract][Full Text] [Related]
11. NG-nitro-L-arginine (N5-[imino(nitroamino)methyl]-L-ornithine) impairs endothelium-dependent dilations by inhibiting cytosolic nitric oxide synthesis from L-arginine.
Mülsch A; Busse R
Naunyn Schmiedebergs Arch Pharmacol; 1990; 341(1-2):143-7. PubMed ID: 2314480
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the inhibitory potencies of N(G)-methyl-, N(G)-nitro- and N(G)-amino-L-arginine on EDRF function in the rat: evidence for continuous basal EDRF release.
Vargas HM; Cuevas JM; Ignarro LJ; Chaudhuri G
J Pharmacol Exp Ther; 1991 Jun; 257(3):1208-15. PubMed ID: 1646327
[TBL] [Abstract][Full Text] [Related]
13. L-arginine and arginine analogues: effects on isolated blood vessels and cultured endothelial cells.
Schmidt HH; Baeblich SE; Zernikow BC; Klein MM; Böhme E
Br J Pharmacol; 1990 Sep; 101(1):145-51. PubMed ID: 2282457
[TBL] [Abstract][Full Text] [Related]
14. Nitroarginine inhibits endothelium-derived relaxation.
Kobayashi Y; Hattori K
Jpn J Pharmacol; 1990 Jan; 52(1):167-9. PubMed ID: 2308237
[TBL] [Abstract][Full Text] [Related]
15. L-glutamine inhibits the release of endothelium-derived relaxing factor from the rabbit aorta.
Swierkosz TA; Mitchell JA; Sessa WC; Hecker M; Vane JR
Biochem Biophys Res Commun; 1990 Oct; 172(1):143-8. PubMed ID: 2222463
[TBL] [Abstract][Full Text] [Related]
16. Thimerosal blocks stimulated but not basal release of endothelium-derived relaxing factor (EDRF) in dog isolated coronary artery.
Crack P; Cocks T
Br J Pharmacol; 1992 Oct; 107(2):566-72. PubMed ID: 1384915
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of L-arginine on the inhibition by NG-nitro-L-arginine methyl ester of basal and agonist-stimulated EDRF activity.
Randall MD; Griffith TM
Br J Pharmacol; 1991 Nov; 104(3):743-9. PubMed ID: 1797335
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of endothelial nitric oxide biosynthesis by N-nitro-L-arginine.
Dubbin PN; Zambetis M; Dusting GJ
Clin Exp Pharmacol Physiol; 1990 Apr; 17(4):281-6. PubMed ID: 2347118
[TBL] [Abstract][Full Text] [Related]
19. Effects of nitro-L-arginine on endothelium-dependent relaxation of canine cerebral arteries.
Ohta F; Kobayashi Y; Shinozuka K; Shimoura K; Hattori K; Moritake K
Clin Exp Pharmacol Physiol; 1993 Jun; 20(6):413-9. PubMed ID: 7687939
[TBL] [Abstract][Full Text] [Related]
20. NG-monomethyl L-arginine inhibits endothelium-derived relaxing factor-stimulated cyclic GMP accumulation in cocultures of endothelial and vascular smooth muscle cells by an action specific to the endothelial cell.
Johns RA; Peach MJ; Linden J; Tichotsky A
Circ Res; 1990 Oct; 67(4):979-85. PubMed ID: 2170053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
